Evidence map›Paper›PMID 39962001›Full record

ReviewAnnals of surgical oncology2025

Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective.

Ryan P Merkow, Michael J Cavnar, Ana L Gleisner, Skye C Mayo, Sepideh Gholami, Paul J Karanicolas, Bas Groot Koerkamp, Marjolein Y V Homs, Louise C Connell, Andrea Cercek and 6 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ryan P Merkow *Department of Surgery, Division of Surgical Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
Michael J Cavnar *Department of Surgery, Division of Surgical Oncology, University of Kentucky, Lexington, KY, USA.
Ana L GleisnerDepartment of Surgery, University of Colorado, Aurora, CO, USA.
Skye C MayoDepartment of Surgery, Division of Surgical Oncology, Oregon Health & Science University and Knight Cancer Institute, Portland, OR, USA.
Sepideh GholamiDepartment of Surgery, Division of Surgical Oncology, Northwell Health Cancer Institute, New Hyde Park, Northwell Health, NY, USA.
Paul J KaranicolasDepartment of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Bas Groot KoerkampDepartment of Surgery, Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
Marjolein Y V HomsMedical Oncology, Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
Louise C ConnellDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andrea CercekDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Paul R HelftDepartment of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA.
Blase N PoliteDepartment of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
Reema A PatelDepartment of Medicine, Division of Medical Oncology, University of Kentucky, Lexington, KY, USA.
Hope E UronisDepartment of Medicine, Division of Medical Oncology, Duke University, Durham, NC, USA.
Michael D'AngelicaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Michael E LidskyDepartment of Surgery, Division of Surgical Oncology, Duke University, Durham, NC, USA. Michael.lidsky@duke.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic arterial infusion (HAI) pump chemotherapy is an effective therapy for colorectal liver metastases and intrahepatic cholangiocarcinoma. In the setting of recent reports suggesting favorable outcomes in these diseases with HAI, there has been a surge in interest in this treatment worldwide, prompting the opening of many new HAI programs. While significant technical expertise is required for pump implantation, this alone is insufficient to open a safe and sustainable HAI program, and numerous other factors must be considered prior to the first pump implantation. This expert perspective, established using an anonymous web-based survey of experienced multidisciplinary international HAI providers, details the minimum required personnel, expertise, training, and infrastructure to optimize success and sustainability of a safe and effective new HAI program.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaColorectal NeoplasmsHepatic ArteryInfusions, Intra-ArterialLiver NeoplasmsHumansExpert perspectiveHAIHAIPHepatic artery infusion pump

Identifiers

PMID39962001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.